As at April 1, 2021
ISSUED & OUTSTANDING
The Novel Technology of ASEP Medical represents tremendous commercial potential as Sepsis is one of the largest unmet clinical needs facing our healthcare system today, and among the most expensive conditions for hospitals to treat. Current methods of diagnosis (including blood cultures) can take over 24 hours and are not fully predictive. This is a rare combination of both a novel diagnostic and therapeutic approach to a multi-billion-dollar problem.
The Company’s founders and management team consists of renown medical researchers, scientists, and experienced executives with proven track records of developing, financing and commercializing proprietary healthcare technologies.
COMING TO THE CSE SOON